Drugs Made In America Acquisition (DMAA) Cash from Operations (2025)

Drugs Made In America Acquisition (DMAA) reported Cash from Operations of 125180.0 for Q4 2025, down 123.11% quarter-over-quarter from 56108.0 in Q3 2025.

Drugs Made In America Acquisition (DMAA) Cash from Operations (2025) Analysis & Trends

Drugs Made In America Acquisition has reported Cash from Operations for 1 years, with the latest figure at 125180.0 in Q4 2025.

  • For the quarter ending Q4 2025, Cash from Operations changed N/A year-over-year to 125180.0; the trailing twelve-month figure through Dec 2025 stood at 539187.0 (changed N/A YoY), and the FY2025 full-year result was 539187.0, down 213.0% from the prior year.
  • Cash from Operations for Q4 2025 stood at 125180.0, down from 56108.0 in the prior quarter.
  • The five-year high for Cash from Operations was 56108.0 in Q3 2025, with the low at 251244.0 in Q1 2025.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Operations (Qtr)
1 EQV Ventures Acquisition 477.69 Mn 477.69 Mn - -121,028.00
2 Berto Acquisition 312.46 Mn 312.46 Mn - -119,667.00
3 Centurion Acquisition 311.65 Mn 311.65 Mn - -72,157.00
4 GP-Act III Acquisition 311.36 Mn 311.36 Mn - 10,832.00
5 Churchill Capital Corp IX 310.79 Mn 310.79 Mn - -334,671.00
6 WEN Acquisition 309.15 Mn 309.15 Mn - -195,797.00
7 Bold Eagle Acquisition 275.54 Mn 275.54 Mn - -171,240.00
8 Soulpower Acquisition 264.91 Mn 264.91 Mn - -1.42 Mn
9 BTC Development 262.16 Mn 262.16 Mn - -537,350.00
10 Drugs Made In America Acquisition 223.11 Mn 223.11 Mn - -125,180.00

Historic Data

Download Data
DateValue
Dec 31, 2025 -125,180.00
Dec 31, 2025 -125,180.00
Sep 30, 2025 -56,108.00
Sep 30, 2025 -56,108.00
Jun 30, 2025 -106,655.00
Jun 30, 2025 -106,655.00
Mar 31, 2025 -251,244.00
Mar 31, 2025 -251,244.00